Cyanotech Corporation (CYAN) financial statements (2022 and earlier)

Company profile

Business Address 73-4460 QUEEN KAAHUMANU HWY
KAILUA KONA, HI 96740
State of Incorp. NV
Fiscal Year End March 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q3
9/30/2021
Q2
6/30/2021
Q1
3/31/2021
Q4
12/31/2020
Q3
9/30/2020
Q2
6/30/2020
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,2982,1341,0613,7673,3224,2533,325
Cash and cash equivalents2,2982,1341,0613,7673,3224,2533,325
Receivables4,5263,0775,0362,4361,6822,0832,013
Inventory, net of allowances, customer advances and progress billings8,7249,8089,2348,4159,58910,07410,094
Inventory8,7249,8089,2348,4159,58910,07410,094
Other undisclosed current assets293339374488430433468
Total current assets:15,84115,35815,70515,10615,02316,84315,900
Noncurrent Assets
Operating lease, right-of-use asset3,4123,5003,4353,5173,5983,6783,757
Property, plant and equipment11,93611,90111,90512,13612,36312,59012,706
Other noncurrent assets112118122120129142163
Total noncurrent assets:15,46015,51915,46215,77316,09016,41016,626
TOTAL ASSETS:31,30130,87731,16730,87931,11333,25332,526
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,5663,0833,6043,1312,2513,2782,680
Accounts payable2,2751,8332,4712,2871,5502,3001,633
Accrued liabilities1,2911,2501,1338447019781,047
Deferred revenue83110156124116198123
Debt6261,0811,7202,2103,9544,1974,215
Other undisclosed current liabilities382373348343338333327
Total current liabilities:4,6574,6475,8285,8086,6598,0067,345
Noncurrent Liabilities
Long-term debt and lease obligation7,4277,5937,7327,9987,2638,8999,153
Long-term debt, excluding current maturities4,4004,4684,6474,8233,9985,5505,719
Operating lease, liability3,0273,1253,0853,1753,2653,3493,434
Liabilities, other than long-term debt20242832343739
Other liabilities20242832343739
Total noncurrent liabilities:7,4477,6177,7608,0307,2978,9369,192
Total liabilities:12,10412,26413,58813,83813,95616,94216,537
Stockholders' equity
Stockholders' equity attributable to parent19,19718,61317,57917,04117,15716,31115,989
Common stock124123122122122122120
Additional paid in capital33,54433,34733,28533,26733,18233,16432,999
Accumulated deficit(14,471)(14,857)(15,828)(16,348)(16,147)(16,975)(17,130)
Total stockholders' equity:19,19718,61317,57917,04117,15716,31115,989
TOTAL LIABILITIES AND EQUITY:31,30130,87731,16730,87931,11333,25332,526

Income statement (P&L) ($ in thousands)

12/31/2021
Q3
9/30/2021
Q2
6/30/2021
Q1
3/31/2021
Q4
12/31/2020
Q3
9/30/2020
Q2
6/30/2020
Q1
Revenues9,4599,4198,9649,0806,9858,5717,352
Cost of revenue
(Cost of Goods and Services Sold)
(6,221)(5,657)(5,292)(7,578)(4,914)(5,270)(4,377)
Gross profit:3,2383,7623,6721,5022,0713,3012,975
Operating expenses(2,730)(2,680)(3,053)(2,243)(2,512)(3,019)(2,707)
Operating income (loss):5081,082619(741)(441)282268
Interest and debt expense(116)(101)(95)1,9191,266(121)(131)
Income from continuing operations before equity method investments, income taxes:3929815241,178825161137
Other undisclosed loss from continuing operations before income taxes   (550)   
Income from continuing operations before income taxes:392981524628825161137
Income tax expense (benefit)(6)(11)(4)262(6)1
Net income available to common stockholders, diluted:386970520654827155138

Comprehensive Income ($ in thousands)

12/31/2021
Q3
9/30/2021
Q2
6/30/2021
Q1
3/31/2021
Q4
12/31/2020
Q3
9/30/2020
Q2
6/30/2020
Q1
Net income:386970520654827155138
Comprehensive income, net of tax, attributable to parent:386970520654827155138

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: